Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Dec 28, 2016
Electrophilic reagents for monohalomethylation, their preparation and their uses
Read more
Scientific Article
/ Dec 28, 2016
Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.
Read more
Scientific Article
/ Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Read more
Scientific Article